Join our Community
Support ToI and remove all ads
Learn more
×

remdesivir

This undated image provided by Merck & Co. shows its new antiviral medication (Merck & Co. via AP)
October 1, 2021, 3:03 pm
Merck says experimental antiviral pill halves COVID-19 deaths, hospitalizations
Pharma giant says will soon seek authorization for the medication’s use; if cleared, would be 1st pill shown to treat those infected with virus, a potentially major advance
By MATTHEW PERRONE
A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, October 15, 2020. (Zsolt Czegledi/MTI via AP)
November 20, 2020, 1:44 pm
WHO advises against using drug remdesivir for treating COVID patients
UN organization claims the medicine, which has received approval as a coronavirus treatment from several health agencies, has ‘no important effect’ on improving survival chances
By Patrick Galey
Rubber stoppers are placed onto filled vials of the drug remdesivir at a Gilead manufacturing site in the United States, March 2020. (Gilead Sciences via AP)
October 23, 2020, 6:46 am
FDA approves first COVID-19 drug: antiviral remdesivir
Medicine found to cut recovery time by five days on average, but no studies have shown it improves chances of surviving the coronavirus
By MARILYNN MARCHIONE
A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, October 15, 2020. (Zsolt Czegledi/MTI via AP)
October 16, 2020, 4:59 pm
WHO says no evidence remdesivir, 3 other drugs, benefit serious COVID cases
6-month trial: Drug used to treat Trump, listed as standard care in US, has ‘little or no effect’ on whether patients die within a month, or whether hospitalized patients recover
By AP
US President Donald Trump arrives at Walter Reed National Military Medical Center, in Bethesda, Md., Oct. 2, 2020, on Marine One helicopter after he tested positive for COVID-19. White House chief of staff Mark Meadows is at left. (AP Photo/Jacquelyn Martin)
October 3, 2020, 9:35 am
White House says hospitalized Trump on remdesivir, but not supplemental oxygen
US president gets anti-viral drug after earlier receiving experimental treatment; tweets from medical facility that it is ‘going well, I think’; campaign manager tests positive
By Agencies
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. (AP/Ted S. Warren, File)
July 23, 2020, 9:04 am
Iran claims to successfully test virus vaccine on animals, move to humans
Top health official also announces development of cheaper version of remdesivir and favipiravir, which are believed to be helpful in treating some serious COVID-19 cases
By ToI Staff
A dose of remdesivir (iStock)
July 12, 2020, 4:59 pm
Cut off in mid-treatment: Israel running out of lifesaving COVID drug remdesivir
Just as treatment wows some Israeli doctors, country’s stocks are dwindling; at least two hospitals can’t get it; in Haifa, a patient in serious condition has his supply halted
By Nathan Jeffay
In this photo taken on May 2, 2020, doctors work inside the intensive care unit for people infected with the new coronavirus, at a hospital in Moscow, Russia. (AP Photo/Sophia Sandurskaya)
July 8, 2020, 10:18 am
‘Desperation science’ slows the hunt for coronavirus medicine
Ironically, attempts to fast-track research on COVID-19 drugs have led to a slew of low-quality studies that add to confusion. And statements by politicians aren’t helping either
By MARILYNN MARCHIONE
A vial of remdesivir is pictured during a press conference about the start of a study with the anti-viral drug at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020. (Ulrich Perrey / POOL / AFP)
July 3, 2020, 6:00 pm
EU authorizes use of remdesivir to treat coronavirus
Bloc’s health chief calls approval of drug, which studies have shown can reduce hospital stays for COVID-19 patients, ‘an important step forward in the fight against this virus’
By AFP
Rubber stoppers are placed onto filled vials of the remdesivir at a Gilead manufacturing site in the US, in March 2020. (Gilead Sciences via AP)
June 16, 2020, 8:05 pm
Israel to accept COVID-19 drug remdesivir from US company
Government backs Health Ministry in authorizing Gilead Sciences’ donation of medicine
By ToI Staff and Agencies
A vial of the drug remdesivir is viewed during a press conference about the start of a study with the drug in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, April 8, 2020, amidst the coronavirus pandemic. (Ulrich Perrey / POOL / AFP)
June 1, 2020, 8:24 pm
Gilead stock drops amid mixed results on drug remdesivir’s effects on virus
Company-led study finds those who who got medication for 5 days improved 65%, while there was no proven difference when getting it for 10 days; more details to be published
By AP and ToI Staff
In this on May 19, 2020 file photo, a chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP/Rafiq Maqbool)
May 23, 2020, 5:01 pm
Big study casts more doubt on malaria drugs pushed by Trump as virus treatment
Researchers estimate death rate slightly higher among those taking hydroxychloroquine; separate study on remdesivir suggests benefit in treating COVID-19
By AP and ToI Staff
Illustrative: A cybersecurity expert stands in front of a map of Iran as he speaks to journalists about the techniques of Iranian hacking, on September 20, 2017, in Dubai, United Arab Emirates. (AP/Kamran Jebreili)
May 9, 2020, 4:24 am
Israeli firm uncovers Iran-linked attempt to hack US virus drugmaker Gilead
Pharmaceutical company is pioneering treatment for coronavirus; ClearSky cybersecurity outfit says Iran-connected hackers are targeting COVID-19 researchers, including in Israel
By ToI Staff
A suspected coronavirus patient is evacuated to Hadassah Ein Karem Hospital in Jerusalem, on March 22, 2020. (Flash90)
May 4, 2020, 9:22 pm
Israel well placed to secure antiviral drug remdesivir — health official
Health Ministry’s Asher Shalmon predicts future ‘spike’ in cases, admits ‘compromises’ and ‘confusion’ in management of economy reopening
By Nathan Jeffay
A vial of the drug remdesivir is viewed during a press conference about the start of a study with the drug in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, April 8, 2020, amidst the coronavirus pandemic. (Ulrich Perrey / POOL / AFP)
May 4, 2020, 1:31 pm
Remdesivir results for virus encouraging but too early to celebrate — local CEO
FDA last week gave emergency approval to medicine produced by Gilead Sciences; it is believed to shorten illness time in some, but effect on mortality rates still unclear
By ToI Staff and AP
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.